Uplifting Athletes to host third annual Young Investigator Draft presented by CSL Behring on March 7 at Lincoln Financial Field in Philadelphia

Uplifting Athletes, a Philadelphia-based non-profit organization that inspires the Rare Disease Community with hope through the power of sport, announced plans today for the third annual Young Investigator Draft, presented by CSL Behring, taking place on Saturday, March 7, 2020 at Lincoln Financial Field, home of the Philadelphia Eagles of the National Football League (NFL).

The football theme of the Young Investigator Draft is inspired by the NFL Draft. Instead of drafting emerging young football talent, this unique draft turns the spotlight on the next generation of promising young medical researchers who are “drafted” and awarded research grants by Uplifting Athletes in order to help them pursue new treatments and potential cures for many of the world’s rarest diseases. 

“The Young Investigator Draft serves as a powerful celebration of research within the field of rare diseases, providing a platform to distribute research funding to up-and-coming young researchers and honoring our ‘Rare Disease Champion Team’,” says Rob Long, Executive Director of Uplifting Athletes. “We’re proud to have already awarded $180,000 in grants over the past two years alone and look forward to continued success. With every new year, we discover brilliant young researchers who help us learn more about these underserved diseases.”

“CSL Behring is proud to continue sponsoring this innovative program that supports emerging science and rare disease research,” added Kevin Kovaleski, Vice President, Global Commercial Development, Transplant, CSL Behring.  “The Young Investigator Draft reinforces our promise to patients by empowering researchers to focus on the rare disease community.”

Uplifting Athletes and its annual Young Investigator Draft focus on rare diseases because they are often underserved and so diverse.  Rare diseases are so prevalent that 1 in 10 Americans are affected by rare diseases. That’s a higher percentage than cancer and AIDS combined. Additionally, they transcend gender, race, age, sexual orientation and socioeconomic status. Unfortunately, due to the large variety and complexity of rare diseases, there is very little support for rare disease research, especially compared to funding for more common diseases such as heart disease and diabetes. Uplifting Athletes exists to close this significant funding gap. 

Uplifting Athletes emphasis for the 2020 Young Investigator Draft is on building greater audience participation for the draft event on Saturday, March 7, 2020, as well as inviting more medical research-related corporate sponsorship and involvement in the event. By doing so, Uplifting Athletes believes it can help transform the way society views, engages with and supports the research that will benefit many future generations. Please visit the Young Investigator Draft Facebook event page to participate in the draft.


Founded in 2007, Uplifting Athletes fulfills its mission to inspire the Rare Disease Community with hope through the power of sport with a powerful network of over 20 college football student-athlete led chapters, Uplifting Ambassadors and Team UA participants.

Since its inception, Uplifting Athletes has raised more than $5 million to support the mission of Uplifting Athletes and its charitable programs: Rare Disease Awareness, Rare Disease Research, Uplifting Experiences and Uplifting Leaders. To learn more, please visit upliftingathletes.org

About CSL Behring

CSL Behring is a global biotherapeutics leader driven by its promise to save lives. Focused on serving patients’ needs by using the latest technologies, we develop and deliver innovative therapies that are used to treat coagulation disorders, primary immune deficiencies, hereditary angioedema, respiratory disease, and neurological disorders. The company’s products are also used in cardiac surgery, burn treatment and to prevent hemolytic disease of the newborn.

CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. The parent company, CSL Limited (ASX:CSL;USOTC:CSLLY), headquartered in Melbourne, Australia, employs more than 25,000 people, and delivers its life-saving therapies to people in more than 70 countries. For inspiring stories about the promise of biotechnology, visit Vita CSLBehring.com/vita and follow us on Twitter.com/CSLBehring

Uplifting Athletes Media Contact: 

Frank Keel 

Office: +1 484 410 4932 

Email: Keelcommunicationsllc@gmail.com

CSL Behring Media Contact

Jennifer Purdue

Office: +1 610 878 4802

Mobile: +1 610 306 9355

Email: jennifer.purdue@cslbehring.com 

Young Investigator Draft grant recipient Dr. David Fajgenbaum pens book about his rare disease journey

For more than five years, Dr. David Fajgenbaum has been a friend, mentor, advisor, inspiration and partner to Uplifting Athletes and the Rare Disease Community.

Dr. Fajgenbaum was a recipient of one of the five research grants awarded at the inaugural Uplifting Athletes Young Investigator Draft in 2018. The research organization he helped launch, Castleman Disease Collaborative Network, which was a priority partner for our Young Investigator Draft initiative in both 2018 and 2019.

His vision as a researcher/scientist and passion to help others is infectious. Uplifting Athletes is extremely fortunate to have a close and personal relationship with Dr. Fajgenbaum.

“It’s been an honor to get to know David and to be able to call him a friend and a mentor,” said Uplifting Athletes Executive Director Rob Long, who was also a rare disease patient. “What he has accomplished, not only for the Castleman community, but the rare disease and medical community as a whole, cannot be understated.

“His humility and kindness are remarkable. We are proud to share David’s story to inspire others who have had the odds stacked against them.”

Dr. Fajgenbaum’s rare disease story is amazing. It has many layers and levels. A snapshot at a conference or as a guest speaker doesn’t do the depth and breadth of his journey justice.

So, Dr. Fajgenbaum added another bullet point to his already robust resume – book author.

Chasing My Cure: A Doctor’s Race To Turn Hope into Action by Dr. David Fajgenbaum is the inspiring memoir of a young doctor and former college football player who became a champion for people suffering from a rare, under-researched disease – all while battling his own.

Dr. Fajgenbaum’s memoir, released by Ballantine Hardcover, is available for sale starting September 10, 2019.

A former Georgetown quarterback nicknamed “The Beast,” David Fajgenbaum was also a force in medical school, where he was known for his unmatched mental stamina. But things changed dramatically when he began suffering from inexplicable fatigue. In a matter of weeks, his organs were failing and he was read his last rites. Doctors were baffled over a condition they had yet to even diagnose; floating in and out of consciousness, Fajgenbaum prayed for the equivalent of a game day overtime: a second chance.

Miraculously, Fajgenbaum survived, but only to endure repeated near-death relapses from what would eventually be identified as a form of Castleman disease—an extremely deadly and rare condition that acts like a cross between cancer and an autoimmune disorder.

When he relapsed on the only drug in development and realized that the medical community was unlikely to make progress in time to save his life, Fajgenbaum turned his desperate hope for a cure into concrete action: between hospitalizations he studied his own charts and tested his own blood samples, looking for clues that could unlock a new treatment.

With the help of family, friends and mentors, he also reached out to other Castleman disease patients and physicians, and eventually came up with an ambitious plan to crowdsource the most promising research questions and recruit world-class researchers to tackle them; instead of waiting for the scientific stars to align, he proposed to align them himself.

“David Fajgenbaum, a self-proclaimed “rare disease quarterback,” shares with us his extraordinary story of assembling a team and a framework to conduct unprecedented collaborative research,” Georgetown University President Dr. John J. DeGioia said. “In his deeply personal memoir, he makes plain the urgency of hope, and explores how the human spirit might transcend suffering to inspire communities to take
 collective action against seemingly insurmountable odds.”

More than five years later and now married to his college sweetheart with a daughter, his hard work has paid off: a treatment that he identified has induced a tentative remission and his novel approach to collaborative scientific inquiry has become a blueprint for advancing rare disease research. His incredible story demonstrates the potency of hope, and what can happen when forces of determination, love, family, faith and serendipity collide.

Rare Disease Community takes over Lincoln Financial Field at 2nd Uplifting Athletes Young Investigator Draft

2019 Young Investigator Draft grant recipients (left to right): Dr. Alberto Japp, Dr. Eugene Hwang, Dr. Shana McCormack, Dr. Elizabeth Harrington, Dr. Brian Sworder and Dr. Brenda Gallie.

Lincoln Financial Field in Philadelphia experienced a Rare Disease Community takeover Saturday night when Uplifting Athletes hosted its 2nd Young Investigator Draft presented by CSL Behring.

And the spotlight at The Linc – home to the NFL’s Philadelphia Eagles – was on the six rare disease research grant recipients drafted by our priority partners to become part of the Uplifting Athletes team.

“We could not of been more excited how the event came together, and what an amazing turnout we had for year two of this event,” Uplifting Athletes Executive Director Rob Long said. “We take pride in our ability to bring together doctors, patients, young investigative researchers, industry partners, rare disease advocates and athletes all together in one room. Each group was well represented.”

Similar to the NFL Draft where teams select the top young prospects they feel can make the most impact on their future, at the Young Investigator Draft, Uplifting Athletes celebrated its 2019 draft class in five different rare disease categories.

The evening started with a social hour that included one-of-a-kind stadium tours of Lincoln Financial Field.

Then it was time to kick off the 2019 Young Investigator Draft and hand out some authentic draft jerseys to research scientists in five rare disease categories: rare cancers, rare autoimmune and immunological disorders, rare blood disorders, rare genetic disorders and rare muscular and neurological disorders.

The 2019 Young Investigator Draft class includes Dr. Shana McCormack, Dr. Elizabeth Harrington, Dr. Alberto Japp, Dr. Eugene Hwang and Dr. Brian Sworder.

Several of the grant recipients said the process of being drafted was a “first” for them and despite being briefed and told how the evening would unfold they said there were no words that fully prepared them for the energy and excitement the evening created.

Young Investigator Draft grants are intended to inspire collaborative and translational research that will benefit the entire Rare Disease Community. The Young Investigator Draft stage provided each doctor a platform to educate and inspire by sharing their research along with its impact on the Rare Disease Community.

The drafted grant recipients were chosen by this year’s priority partners: Accelerate Brain Cancer Cure, Castleman Disease Collaborative Network, Friedreich’s Ataxia Research Alliance, Leukemia Lymphoma Society and Project ALS.

Each priority partner had a guest presenter make the selection. The 2019 list of guest presenters included Kyle Bryant, BethAnn Telford, Dr. David Fajgenbaum, Malik Turner and Adam Breneman.

After draft emcee Stephanie Stahl, a health reporter for media sponsor CBS 3 of Philadelphia, closed the draft it was time for a couple special presentations.

Dr. Brenda Gallie of Children’s Hospital in Toronto received the Uplifting Athletes Young Investigator Draft Collaborative Leadership Award for her decades of commitment to eradicating the rare eye disease retinoblastoma.

She was introduced via video by former USC long snapper and 2016 Uplifting Athletes Rare Disease Champion Award winner Jake Olson, who is legally blind after losing both is eyes to retinoblastoma.

To bring down the curtain on the evening, the 11th winner of the Uplifting Athletes Rare Disease Champion Award, University of Kansas football coach Joshua Eargle, took the stage and delivered a moving and inspirational speech.

Coach Eargle shared the story of his family and their rare disease journey with their daughter Landrey. For nearly six years the Eargle’s stayed quiet about their struggles with the extremely rare diagnosis for Landry.

After sharing their story publicly for the first time in 2019, doors and avenues have opened they never imagined. This has inspired Coach Eargle and his wife Kristen and made them even stronger advocates for the Rare Disease Community.

Uplifting Athletes would like to thank everyone who attended our 2nd Young Investigator Draft and a special thanks to all of our sponsors for making this unique approach to rare disease research possible.

In addition to CSL Behring as our presenting sponsor, Sanofi Genzyme, Horizon, PRA Health Sciences, Retrophin, Bristol-Myers Squibb, Spark Therapeutics, Strongbridge BioPharama, Amicus Therapeutics, We Work For Health (WWFH) and Ultragenyx all contributed to the success of the 2019 Young Investigator Draft.

“It took a lot of teammates who believe in the mission of Uplifting Athletes and have passion for the rare disease cause to make all this happen,” Long said. “The fact that our priority partners joined us in co-funding each grant recipient so that we could direct more than $120,000 directly to the young investigator rare disease researchers to be used at their discretion to support their research is a game changer.”

Dr. Shana McCormack to receive Rare Genetic Disorders research grant at 2019 Young Investigator Draft presented by CSL Behring

The Young Investigator Draft is the result of Uplifting Athletes’ ongoing commitment to cultivate resources that accelerate scientific advancements for rare disease treatments and potential cures while facilitating the next generation of rare disease researchers.

These Young Investigators will pursue rare disease research in one of five different areas: rare cancers, rare autoimmune and immunological disorders, rare blood disorders, rare genetic disorders and rare muscular and neurological disorders.

To learn more about the Young Investigator Draft and to purchase tickets click here.

Researcher: Dr. Shana McCormack

Category: Rare Genetics Disorders

Education: Dr. McCormack started her education at Harvard where she studied biochemistry. She obtained her MD from Harvard Medical School and Massachusetts Institute of Technology, did her internship and residency in pediatrics at Massachusetts General Hospital in Boston. Dr. McCormack did her fellowship in pediatric endocrinology at Children’s Hospital Boston completed her education with a Master of Science in Translational Research (MTR) from the University of Pennsylvania Perelman School of Medicine. Currently, Dr. McCormack is an attending physician and Scientific Director of the Neuroendocrine Center in the Division of Endocrinology and Diabetes at Children’s Hospital of Philadelphia (CHOP). She also serves as a member of the clinical research team for Mitochondrial Medicine at CHOP.

Research: As a physician-scientist, Dr. McCormack investigates the neuroendocrine systems that regulate energy balance in humans. Her translational research program has two main areas of focus. First, she studies individuals with metabolic disorders with characterized by risk for diabetes mellitus, including primary mitochondrial diseases, Friedreich’s ataxia, and lipodystrophy. Second, she focuses on brain disorders associated with excess weight gain, including brain-tumor related hypothalamic obesity syndrome and pseudotumor cerebri syndrome/idiopathic intracranial hypertension.

In Their Words: “I have always enjoyed athletics, science and helping people. My mom is a nurse and my dad is an engineer. So it was fairly well laid out for me. I was an athlete in college and played sports in college. So exercise was always important to me. When you think about exercise and assess its value, exercise is very compelling the impact it can have. And now I’m working on projects that bring me back to that. There’s a lot of collaboration and we are finding a lot of cross-pollination and it’s very exciting because we are all looking for ways to help people. I feel very grateful to be sitting at this nexus of opportunity.” – Dr. Shana McCormack

Dr. Shana McCormack has a very busy life with a husband who is a surgeon-scientist, two kids under the age of 10 and her own diverse career as a physician-scientist.

A lot of time is dedicated to being Dr. McCormack and mom. The family loves to be outdoors and hike together. But anybody who’s ever been a parent to a 9 and 7-year-old can attest to what that crazy day-to-day schedule looks like.

Just talking to Dr. McCormack, though, you can tell she’s very passionate and inspired by the work she does. The scientific side she called “fascinating” but in the end she said the key is a strong desire to help people.

Her work recently has taken her down a path where exercise is part of a scientific equation and it has brought along a little nostalgia to her days at Harvard as a student-athlete.

Dr. McCormack held down position No. 7 on the Harvard 1997 Intercollegiate Rowing Association National Championship winning women’s light rowing crew. And as she told the story of that team and winning it all, she noted most of her fellow crew members on that team are either physicians or scientists or have sports and athletics involved in what they do professionally.

“We all are busy and I certainly have enough to keep me busy on any given day,” Dr. McCormack said. “I love my kids and they are so much fun. I love they are both interested in science. But as I talk about rowing and winning a national championship I know it’s something I want to get back into. So this summer I’m going to get back into rowing.”

Dr. Eugene Hwang to receive Rare Cancers research grant at 2019 Young Investigator Draft presented by CSL Behring

The Young Investigator Draft is the result of Uplifting Athletes’ ongoing commitment to cultivate resources that accelerate scientific advancements for rare disease treatments and potential cures while facilitating the next generation of rare disease researchers.

These Young Investigators will pursue rare disease research in one of five different areas: rare cancers, rare autoimmune and immunological disorders, rare blood disorders, rare genetic disorders and rare muscular and neurological disorders.

To learn more about the Young Investigator Draft and to purchase tickets click here.

Researcher: Dr. Eugene Hwang

Category: Rare Cancers

Education: Dr. Hwang started his education with an undergraduate degree in cell and molecular biology from Rice University. He went to medical school at Duke University where he obtained his MD. Dr. Hwang did his residency in pediatrics at Brown University’s Hasbro Children’s Hospital, returned to Duke University for his fellowship in pediatric hematology-oncology and was the Chief Fellow his final year. Dr. Hwang’s final post-graduate training was also at Duke University in pediatric neuro-oncology. He is currently a pediatric neuro-oncologist at the Children’s National Medical Center and cares for children with brain tumors.

Research: In Dr. Wang’s words this is his focus when it comes to research “I’m a clinical/researcher and I’m thinking and designing on the translational side for that make sense to me and what the FDA and governing bodies will allow. We open research to single hospitals or groups of hospitals. The hospital I’m at now has become a leader for pediatric brain cancer. Through that vain we are able to propose and run through the same consortium. There’s always a lot of rationale to choose the drugs we are going to test. Pediatric brain cancer funding is limited, so these are all clinical trails. There are a lot of collaborations, but in many ways it what we are trying to accomplish to find what helps to make a difference with children. I need to know cutting edge to know what is going on with science and with the treatment of patients. Sometimes it’s hard to get researchers and doctors together to make it meaningful to everyone. I can dialogue with both sides of the equation and it’s proven helpful.”

During his third year of medical school, Dr. Hwang was drawn to children and he knew his future would include pediatric medicine. He had discovered his passion and purpose.

Science and medicine wasn’t necessarily his first love. For Dr. Hwang, who grew up in Texas and is the father of two daughters, it was a process.

His first love was literature and for the first half of college he was fairly certain he was going to be a writer. And even today he says that would have been a fulfilling career.

Science was always something that came easy for Dr. Hwang growing up, but it was a process for him to let go of his first love – literature and writing – and commit to a career path of making a difference in the lives of others.

“There’s something special about when a child is sick as compared to an adult. There’s something moving about a family coming around a sick child. The intense emotional energy around a kid who is sick moves me,” said Dr. Hwang, who added he chose to focus on the brain because it remains such a mystery and has always been the most intriguing. “I love that fight that mobilizes immediately when it’s your child or a loved ones child. It was just an easy step to brain cancer for me because I was already drawn to the brain. The survival for pediatric brain cancer is still not great, so the way I see it there are the biggest gains to be made going forward.”

A big fan of the outdoors, including being “great at fly fishing”, Dr. Hwang is also a huge fan of Duke University basketball. Did he paint himself in blue and white and attend Blue Devils games as a Cameron Crazy during his five years at Duke? Of course was his answer.

Dr. Hwang also enjoys photography old-school style, including the magic that comes when working in a darkroom.

But making a difference by helping children with brain tumors is what has made Dr. Hwang one of the very best in his field.

In an article published online by connectionasco.org last November entitled “I Live to Conquer Cancer,” Dr. Hwang laid out what motivates him today as a clinician/researcher.

“I have attended end-of-treatment parties where I finally see the true breadth of the threads that tie all of us together; I have spoken at standing room-only funerals where sorrow and remembrance permeate because of the loss of a child, decades too early,” he wrote. And, at every step of the way, I am continually reminded of why I cannot stop working in this field.

“I am honored and grateful that I have the chance to meet these tiny (and not-so-tiny) warriors, that each family pulls me into the inner sanctum of their loved ones, and that in some small way, I can provide hope for every child.”

Dr. Alberto Japp to receive Rare Autoimmune and Immunological Disorders research grant at 2019 Young Investigator Draft presented by CSL Behring

The Young Investigator Draft is the result of Uplifting Athletes’ ongoing commitment to cultivate resources that accelerate scientific advancements for rare disease treatments and potential cures while facilitating the next generation of rare disease researchers.

These Young Investigators will pursue rare disease research in one of five different areas: rare cancers, rare autoimmune and immunological disorders, rare blood disorders, rare genetic disorders and rare muscular and neurological disorders.

To learn more about the Young Investigator Draft and to purchase tickets click here.

Researcher: Dr. Alberto Japp

Category: Rare Autoimmune and Immunological Disorders

Education: Dr. Japp is a native of Brazil and went to Universidade Federal do Rio de Janeiro (UFRJ) for his undergraduate work and obtained a Bachelor’s Degree in Pharmacy. He then moved to Berlin, Germany and received his Master’s degree in Molecular Medicine from Charite. Dr. Japp stayed in Berlin and attended Humboldt University of Berlin where he obtained his Doctor of Philosophy – PhD, Biology, Immunology. His currently a Postdoctoral Fellow at the University of Pennsylvania as a postdoctoral researcher in immunology.

Research: According to Dr. Japp his research is focused on autoimmune disorders and how the body fights infections and this research is also powerful against cancer. My work here is focused on the de-regulation, how the immune system harms the body in different diseases including Castleman’s Disease and Type 1 diabetes. By studying the underlying mechanisms of the immune system we can learn more about the way to treat and cure these diseases. My work here is focused on human diseases exclusively. Research is also done on animals, but the work I do exclusively human research.

In Their Words: ““Doing research in different countries has been an amazing experience. Each country has a different style. In Germany, I have acquired huge technical skills and learned to be organized. In the U.S., I have learned to communicate with other researchers and apply those skills in highly collaborative projects. The excitement around research here in the U.S. motivates me to be more daring and try new and exciting things.” – Dr. Alberto Japp

Dr. Alberto Japp grew up in Rio de Janeiro in Brazil as the middle child with a brother and sister. He was always fascinated by science growing up – particularly biology and chemistry – and that led him to make a bold decision to leave his home country and family to learn more about how the body works.

He spent nearly a decade in Germany and he loved living in Berlin and furthering his education and abilities as a scientist but he was drawn to expanding his base of knowledge as a research scientist.

“I really enjoyed Berlin and was very happy there, but I had an opportunity to learn more and having another opportunity in science here in the U.S. fascinated me,” Dr. Japp said. “I really wanted to continue doing research and the U.S. is one of the biggest biomedical research centers in the world. My mentor in Germany knew the person who would be my mentor here in the U.S. and both thought it would be perfect because of my interest in immunology research.”

Dr. Japp’s wife Seda came to the United States six months early to get them set up. But For nearly two years Dr. Japp has been working in a collaborative and innovative setting doing cutting edge research.

“The environment at Penn is amazing. It has so many research groups using a lot of techniques and there’s a lot of interaction and collaboration with the groups here,” Dr. Japp said. “When I got here I met Dr. David Fajgenbaum and we started working together and it’s been amazing.

“Castleman’s Disease, being a rare disease, it’s hard to find samples to study. I hadn’t heard of the disease before this. But I learned about it and David has all the samples here at Penn for us to study. There’s so much interesting data to study and we’ve pursued it and are making some really interesting progress.”

Dr. Brian Sworder to receive Rare Blood Disorders research grant at 2019 Young Investigator Draft presented by CSL Behring

The Young Investigator Draft is the result of Uplifting Athletes’ ongoing commitment to cultivate resources that accelerate scientific advancements for rare disease treatments and potential cures while facilitating the next generation of rare disease researchers.

These Young Investigators will pursue rare disease research in one of five different areas: rare cancers, rare autoimmune and immunological disorders, rare blood disorders, rare genetic disorders and rare muscular and neurological disorders.

To learn more about the Young Investigator Draft and to purchase tickets click here.

Researcher: Dr. Brian Sworder

Category: Rare Blood Disorders

Education: Dr. Sworder received his undergraduate degree in biology from UCLA before receiving his MD/PhD in molecular medicine from the Boston University School of Medicine. He was an HHMI-NIH Research Scholar for 22 months at the Howard Hughes Medical Center and was an Internal Medicine Resident at Icahn School of Medicine at Mount Sinai for two years.

Research: At Stanford Dr. Sworder’s research is focused on lymphoma and the various types of lymphoma – specifically B-cell non-Hodgkins lymphoma. Every B-cell or non-Hodgkins lymphoma has a receptor and it’s the same on every cell and it’s the same on every person. Dr. Sworder’s research is aiming to hit targets using new technology to see if they can design a receptor for people who haven’t responded well to chemotherapy.

In Their Words: “The patients we work with are fine day and the next day they have this horrible diagnosis and they are scared and anxious. It’s a lot … and sometimes it’s really hard. But it’s also incredibly rewarding. It is always a privilege to have people trust you enough to share those fears and anxieties with you and to hopefully be able to help them. That draws me to still want to do clinical medicine – to make things better when possible because we can’t help everybody. When somebody struggles it frustrates me and drives me to try and figure out how can we do better. That’s why I want to do science and clinical medicine.” – Dr. Brian Sworder

Dr. Brian Sworder is currently a Hematology and Oncology Fellow at Stanford University School of Medicine. He grew up in Orange County, California and went to Foothill High School where he played volleyball and first became intensely interested in science.

He majored in biology at UCLA and still was unsure what his career path was going to look like. So he took a year off and contemplated whether he wanted to be a teacher or pursue medical school.

During his year off he worked in a clinical laboratory to get a little experience while he applied to medical school was where he became extremely interested in both the research and clinical side of medicine.

“I got into it first for patients and to use research to change things and make it better … but more for the patients,” Dr. Sworder said. “In my first year of medical school I did a research internship with a research scientist and got an internship at the NIH.  That’s what I realized what I wanted to do and understood that I wanted to research that impacts people and makes a difference in their care. In the middle of medical I actually did the research and got my PhD then went back to medical school.

“The synergy between clinical care and scientific research was a perfect opportunity for me in oncology. Today, I do more research than clinical work and it’s sort of flipped for me over time.”

Dr. Sworder was part of the team that recently treated 2019 Uplifting Athletes Rare Disease Champion finalist Ryan Beecher. The Stanford Cardinal linebacker was diagnosed with a rare form of non-Hodgkins lymphoma prior to Stanford’s 2017 bowl game. Beecher underwent his treatment protocol and was able to return to the field for the start of the 2018 season.

“Ryan is an incredible young man,” said Dr. Sworder, who recently was married to Catharine and is a huge fan of the Los Angeles Dodgers and Lakers. “Ryan was getting chemo and was asking me if he could still go to class. I was like ‘sure you can go but you don’t have to go.’ I wouldn’t have been able to get out of my bed. As soon as we were done, he went right back to training. He was an amazing patient.”